First U.S.-based biopharmaceutical partner to join global consortium to accelerate discovery of new treatments for neglected diseases. The biopharmaceutical company Celgene has become the fifth company to join the “Neglected Tropical Diseases Drug Discovery Booster” consortium, a new initiative to accelerate and cut the cost of early stage drug discovery for two of the world’s…